All Episodes

Pan-Cancer Analysis Identifies Buckwheat-Derived Compound as Potential AKT1 Drug-Design Candidate

Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer

Gut Microbiome Emerges as a Potential Partner in Precision Cancer Therapy

DHHC3 Helps Melanoma Tumors Evade Antitumor Immunity

Commentary Calls for Consistent Evaluation of Potential Links Between COVID-19, Vaccination and Cancer

Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers

Therapeutic HPV Vaccine PepCan Tested for Preventing Head and Neck Cancer Recurrence

Oncotarget Supports WIN 2026 Symposium Advancing Precision Oncology

Tumor-Derived Extracellular Vesicles Show Promise for Earlier Detection of Metastatic Risk

Tumor-Infiltrating Lymphocyte Therapy Offers a Promising Approach for Treating Solid Tumors

KRAS G12C Mutation Identified as a Rare Potential Target in Genitourinary Cancers

New Analysis Challenges Methods Used to Measure Residual DNA in mRNA Vaccines

Experimental Compounds Push Cancer-Promoting Pathways Into Overdrive in Pancreatic Cancer Cells

Trk and IGF1R-Related Signaling Linked to Delayed Ewing Sarcoma Growth

CTHRC1 in the Tumor Microenvironment Drives Colorectal Cancer Growth in Mouse Study

Artificial Intelligence Could Transform Nutrition Care for Cancer Patients

Molecular Tumor Board Explores Personalized Treatment Strategies for Patient with Multiple Cancers

Rare Genetic Combination in Gastrointestinal Tumor Offers New Insights Into Precision Cancer Care

Rare Benign Kidney Tumor Case Highlights Value of Biopsy and Minimally Invasive Treatment

Targeted Therapies Coincided With Dramatic Decline in Multiple Myeloma Mortality in the US

TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer

Protein Linked to Melanoma Growth May Suppress the Body’s Natural Anti-Tumor Immune Response

PDX1 May Link Metabolic Dysfunction to Prostate Cancer Progression

HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence

Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer

Cancer Care Often Overlooked in Humanitarian Crises

Protein in Tumor Microenvironment Found to Promote Colorectal Cancer Growth and Immune Evasion

Immune Checkpoint Inhibitors May Improve Outcomes in High-Risk Solid Tumors

Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy

Agentic AI Systems May Transform Nutritional Care in Oncology

Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology

Mapping the Hidden Structure of Glioma Research: What Are We Missing?

Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the U.S.

SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing

Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression

Cancer Care in Conflict Zones Remains Critically Neglected

Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency

CREB5: A Master Regulator of Stem Cell-Like Programs in Prostate Cancer Progression

Adjuvant PD-1/PD-L1 Inhibitors Show Efficacy but Highlight Safety Considerations in Solid Cancers

Bibliometric Mapping Reveals the Evolution of Glioma Classification Research

The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells

Predicting Colorectal Cancer Survival: How Machine Learning Combines Clinical and Biological Clues

CREB5 Linked to Stem Cell-Like Programs That Promote Prostate Cancer Progression

Impact Journals to Participate at AACR Annual Meeting 2026 in San Diego

CAR-T Cell Therapy: A Revolutionary Approach to Cancer Treatment

mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review

Next-Generation CAR-T Designs That Could Transform Cancer Treatment

Researchers Question Editorial Bias in COVID-19 Vaccine Debate

Case Report Explores Potential Link Between mRNA COVID-19 Vaccines and Cancer

How HPV and COVID-19 Spike Proteins May Interact to Impact Cancer Suppression

Exploring Possible Links Between COVID-19 Vaccination, Infection, and Cancer

Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy

New Hypothesis Links HPV E6 and SARS‑CoV‑2 Spike Proteins to Reduced p53 Activity

Evaluation of Cancer Reports Following COVID-19 Vaccination and Infection

Colorectal Cancer Survival Predicted by AI Using Clinical and Molecular Features

Comprehensive Genomic Profiling in Cancer: Insights from Over 10,000 Tumors

Repurposing Statins: Exploring Anti-Tumor Effects in Colorectal Cancer

New Antibody Removes Tregs to Boost Immune Response Against Cancer

Probiotic Bifidobacterium May Boost Cancer Treatment and Suppress Tumors

Clinical Trial Participants Call for More Inclusive, Patient-Centered Cancer Research

Lower LRIG1 Expression Linked to Aggressive Gliomas

Eco-Friendly Nanoparticles Improve Cidofovir’s Anticancer and Antiviral Effects

How Low Oxygen Shields Prostate Cancer from Ferroptosis Therapies

Genetic Study Identifies Potential Diagnostic Marker for Rare Blood Cancer BPDCN

Folate Receptor Beta Found in Pediatric Tumors May Improve Fluorescence-Guided Cancer Surgery

New Radiofrequency Therapy Slows Glioblastoma Growth and Targets Tumor Stem Cells

New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil

Engineered Bacterial Therapy Activates Immune Response in Cancer Preclinical Studies

Wafik S. El-Deiry Chairs 2025 WIN Symposium in Collaboration with APM in Philadelphia

Precision Oncology in Metastatic Colorectal Cancer: A Real-World Case Study

Loss of Trp53 Gene Promotes Tumor Growth and Immune Suppression in Ovarian Cancer

Immunotherapy Response in Pancreatic Cancer: What a New Study Reveals

Blocking Protein Control Pathway Slows Rhabdomyosarcoma Growth in Mice

Behind the Study: R-spondin Family Roles in Metastatic Prostate Cancer

Amivantamab Monotherapy in Rare EGFR-Mutated Advanced NSCLC

Aramchol Boosts Regorafenib Effectiveness in Gastrointestinal Tumors

FDA-Approved MI Cancer Seek Test Enhances Tumor Profiling for Precision Oncology

New Compound Disrupts Survival Pathways in Aromatase Inhibitor-Resistant Breast Cancer Cells

Cigarette Smoke and Weak DNA Repair: A Double Hit Behind Lung Cancer Risk

New Gene Linked to Aggressive, Treatment-Resistant Prostate Cancer

A New Way to Target Resistant Prostate Cancer Cells

Comprehensive Genomic Testing Reveals Treatment Targets in 90% of Advanced Solid Tumors

Blood Filtration Stabilizes Advanced Pancreatic Cancer: A Case Report

Cholesterol-Lowering Drugs Show Promise Against Colorectal Cancer

microRNAs Emerge as Biomarkers and Diagnostic Tools in Soft Tissue Sarcoma

New Antibody Selectively Targets Immune Cells That Suppress Anti-Tumor Responses

PRDX1 Identified as Key to Chemotherapy Resistance in Cancer Cells

Prostate Cancer Cells Survive Treatment by Storing Fat in Low Oxygen Conditions

EGFR-Targeted Therapy Resistance in Breast and Head & Neck Cancers

Key Genetic Alterations and Biomarker for Blastic Plasmacytoid Dendritic Cell Neoplasm

Immunotherapy Safety for Hepatocellular Carcinoma in Latin America: Insights from a Real-World Study

New Drug Combination Redefines First-Line Treatment for Advanced Urothelial Cancer

HER2-Mutated NSCLC in Brazil Shows Diverse Genetic Patterns and Treatment Gaps

WIN International Molecular Tumor Board Recommends Tailored Treatment for Advanced Colorectal Cancer

CHEK2 Identified as a Potential Target to Improve Immunotherapy in Solid Tumors

Rare Pancreatic Cancer Patients Show Strong Response to Immunotherapy

Exploring a Combined Approach: Radiation and Immunotherapy in Bladder Cancer

Balancing Time, Cost, and Quality in Cardio-Oncology Care

Rare Non-Small Cell Lung Cancer with Brain Metastases Responds to Amivantamab Monotherapy

Oncotarget Sponsors Open Access Team in 2025 Ride for Roswell